Clinical Trial Update: Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating venetoclax with sequential busulfan, cladribine, and fludarabine phosphate as conditioning before donor stem cell transplant in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• Cladribine (cladribine)
• Fludarabine phosphate (Fludarabine phosphate)
• Venclexta (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING